| Treatment of pulmonary hypertension |
|
Wook-Jin Chung |
|
가천의과학대학교 의학전문대학원 길병원 심장내과, 가천심혈관연구소 |
| 폐고혈압의 치료 |
|
정욱진 |
|
Division of Cardiology, Department of Internal Medicine, Gil Hospital, Gachon Cardiovascular Research Institute, Gachon University School of Medicine, Incheon, Korea |
|
|
|
|
| Abstract |
|
Most commonly encountered pulmonary hypertension is pulmonary venous hypertension (PVH) accompanying elevated left
ventricular filling pressure. So, the treatment for the underlying left heart disease should be mainstay of PVH treatment. On the contrary,
pulmonary arterial hypertension (PAH) is an ‘orphan’ disease, which means a very rare one. To the date, PAH have been one
of diseases showing high mortality rate. But, recently, ‘targeted therapies’ were introduced and several novel treatment guidelines
for PAH were recommended. This review discusses new insights into the recent trend focusing on novel therapies and the necessity
of specialized referral centers for PAH in Korea. (Korean J Med 78:28-35, 2010) |
| Key Words:
Pulmonary hypertension; Therapy |
|
PDF Links
Full text via DOI
Download Citation
